The term long non-coding RNA (lncRNA) refers to a group of RNAs with length more than 200 nucleotides, limited protein-coding potential, and having widespread biological functions, including regulation of transcriptional patterns and protein activity, formation of endogenous small interfering RNAs (siRNAs) and natural microRNA (miRNA) sponges. Intervertebral disc degeneration (IDD) and osteoarthritis (OA) are the most common chronic, prevalent and age-related degenerative musculoskeletal disorders. Numbers of lncRNAs are differentially expressed in human degenerative nucleus pulposus tissue and OA cartilage. Moreover, some lncRNAs have been shown to be involved in multiple pathological processes during OA, including extracellular matrix (ECM) degradation, inflammatory responses, apoptosis and angiogenesis. In this review, we summarize current knowledge concerning lncRNAs, from their biogenesis, classification and biological functions to molecular mechanisms and therapeutic potential in IDD and OA. are the most common chronic, prevalent and age-related degenerative musculoskeletal disorders, leading to an enormous socioeconomic burden worldwide. IDD and OA are two major causes of disability and chronic pain, and their incidence has been increasing not only among older persons but also within younger adults in the past decades. It is estimated that approximately 80% adults will suffer chronic low back pain caused by IDD during their lifetime.
ncRNAs, with less than 200 nucleotides, comprise several distinct types of ncRNAs, such as microRNAs (miRNAs), small-interfering RNAs (siRNAs) and Piwi-interacting RNAs (piRNAs).
7 Long non-coding RNAs (lncRNAs), earliest identified from cDNA in 1991, are defined as RNA>200 nucleotides in length without an open reading frame (ORF). 8, 9 Current GENCODE annotation for humans (v25) lists over 15767 lncRNAs. Like miRNAs, lncRNAs are also thought to be major contributors to normal cellular physiological processes and their expression patterns are tissue-and cell-specific. 10 Although studies on lcnRNAs are still in their infancy, they have emerged as critical players in the onset and development of OA and IDD. 11, 12 In this review, we overview the biogenesis, classification and functions of lncRNAs, and focus on their emerging pathological implications and therapeutic potential in IDD and OA.
| BIOGENESIS AND CLASSIFICATION OF LNCRNAS
The vast majority of lncRNAs are produced by the same transcriptional machinery as are other mRNAs, as evidenced by RNA polymerase II (Pol II) occupancy and histone modifications related to transcription initiation and elongation. 13 These lncRNAs possess a 5′ terminal methylguanosine cap and are usually spliced and polyadenylated. 14 In addition, alternate pathways have been found to promote the generation of some lncRNAs. 15 These pathways include a poorly characterized contingent of non-polyadenylated lncRNAs likely expressed from RNA polymerase III promoter, 10, 16 and lncRNAs that are excised during splicing and snoRNA biogenesis. 17 Based on their locations and characteristics, lncRNAs can be classified into five subgroups ( Figure 1 ): (1) sense (when it overlaps with one or more exons of another transcript on the same strand), (2) antisense (when it overlaps with one or more exons of another transcript on the opposite strand), (3) bidirectional (when its transcription and a neighbouring coding transcript on the opposite strand is initiated in close genomic proximity), (4) intergenic (when it lies within the genomic interval between two genes) and (5) intronic (when it transcribes from an intron of a second transcript). 18 However, given the fact that one type of lncRNAs shares with the characteristics of other types of ones, this categorization still remains controversial. 19 A more accurate categorization of lncRNAs is required to investigate their functions.
| BIOLOGICAL FUNCTIONS OF LNCRNAS
As may be expected from their structural diversity, a wide range of biological functions have been described for lncRNAs. These functions primarily include gene transcription, epigenomic regulation, translation of protein-coding genes, RNA turnover, chromatin organization and genome defence. 20, 21 It is worth noting that most of the functions described to date are implicated in regulation of gene expression, both of protein-coding genes and other non-coding RNAs, through a multitude of mechanisms of action as presented in Figure 2 . 
| ROLE OF LNCRNAS IN IDD
The intervertebral disc (IVD) is a viscoelastic weight-bearing "cushion" and plays a crucial role in the maintaining flexibility and stability of the spine. It consists of three morphologically distinct regions: nucleus pulposus (NP), annulus fibrosus (AF) and cartilaginous end plates (CEPs). Its central region is the NP, which is surrounded by the AF laterally and CEPs inferiorly and superiorly. NP is a gelatinous matrix that is rich in type II collagen (Col II) and proteoglycans, especially aggrecan. 35 AF is a thick, dense structure, and it is divided into the outer and inner annulus. The extracellular matrix (ECM) in the outer annulus is dominated by type I collagen (Col I) and also contains relatively low amounts of proteoglycans; however, the inner annulus is made up of both Col I and Col II, with a higher proteoglycan content.
It is worth noting that the IVD is the largest avascular structure in the body, with nerve endings only reaching the inner annulus. 36 Because of these structural features, degeneration is apt to occur within the
IVD.
IDD is the most common cause of chronic low back pain, a public healthy question severely affecting quality of life. It constitutes the pathological foundation of most musculoskeletal disorders of the spine, including spinal stenosis, structural instability, disc herniation, radiculopathy and myelopathy. 1 The aetiology of IDD is currently attributed to the interaction between environmental and genetic factors ( Figure 3) . Notably, environmental factors such as vibration, mechanical loading, physical activities and tobacco smoking are responsible for only a small portion of IDD. [37] [38] [39] In contrast, genetic heredity is the predominant risk factor for degenerative disc disease and is estimated to cause over 70% of cases. 40, 41 Although the pathogenesis of IDD is not completely understood, it is well established that progressive loss of ECM, cell proliferation, inflammatory response, angiogenesis, apoptosis, autophagy, and oxidative stress play critical roles in the occurrence and development of disc degeneration. [42] [43] [44] [45] [46] [47] Like the well-known short non-coding RNAs such as miRNAs, 1 ln- 49 Overexpression of FAF1 is known to potentiate Fas-mediated apoptosis and suppress the degradation of ubiquitinated proteins, leading to a significant increase of cell death. 50, 51 These authors also
found that in addition to upregulation of the nearby enhancer-like lncRNA, RP11-296A18.3, FAF1 is significantly increased in degenerative discs compared with the normal discs. 48 It has been reported that enhancer-like lncRNAs are able to activate the proximal promoter and then stimulate transcription of their nearby coding genes. However, this speculation needs to be further validated by experimental evidence, and whether other differentially expressed lncRNAs are implicated in IDD is yet to be investigated.
| ROLE OF LNCRNAS IN OA
OA, also called osteoarthrosis deformans, is the most common form of arthritis worldwide. As a highly heterogeneous disease, it affects all synovial joints, including the hand, knee, hip and spine. The major pathological features of OA are characterized by the progressive degradation of the articular cartilage along with secondary bone remodelling and episodic synovitis. 56 There has been a large body of evidence supporting that ageing is the most important aetiological risk factor. 57, 58 Other factors such as obesity, genetics and acute destabilising joint injuries also contribute to the development and progression of OA. [58] [59] [60] [61] [62] Although the underlying molecular mechanisms are not fully understood, it is generally known that ECM disruption, 63, 64 
| lncRNAs regulate ECM degradation
Disruption of the articular cartilage followed by remodelling of the underlying bone is the hallmark of OA. Knockout of HoxA-13 has been shown to cause digital reduction. 92 Also, mis-expression of HoxA-13 in chick limb leads to homeotic transformation of the cartilage condensations and reduces cell death by altering cell adhesiveness in chick limb buds. 93 In human OA chondrocytes, HOTTIP expression is significantly increased, with concurrent downregulation of HoxA-13. 94 Moreover, introduction of HoxA-13 siRNA to human OA chondrocytes markedly decreases integrin-α1 levels. 94 Of important, overexpression of integrin-α1 subunit contributes to chondrogenesis, and mice lacking integrin-α1 develop cartilage degradation at a younger age and show increased MMP-2 synthesis. 95 Thus, HOTTIP may promote the degradation of cartilage ECM by suppressing the HoxA-13/integrin-α1/MMP-2 signalling pathway, which plays an important role in the pathogenesis of OA. Nevertheless, this speculation needs to be further proved by experimental evidence, and whether HOTTIP can affect other MMP production for ECM loss in
OA is yet to be investigated.
In addition to lncRNA-CIR, HOTAIR, H19 and HOTTIP, GAS5
is associated with modulation of ECM anabolism and catabolism in chondrocytes. GAS5 was originally identified from a subtraction cDNA library and named after the finding that its expression levels increased upon growth arrest in mammalian cells. 96 It is located at 1q25 and contains 12 exons that are alternatively spliced to produce two possible mature lncRNAs (GAS5a and GAS5b) and 11 introns. These introns can encode 10 box C/D snoRNA. In spite of its short ORF, GAS5
does not possess protein-coding capacity and serves as a so-called host gene for snoRNAs. 97 In SK-Mel-110 cells, a human melanoma cell line, overexpression of GAS5 markedly downregulates the expression of MMP-2, leading to reduced migration and invasion ability. 98 Conversely, GAS5 levels are higher in human OA chondrocytes than those in normal chondrocytes, and its exogenous induction in human OA chondrocytes diminishes miR-21 levels and then increases the expression of MMP-2, MMP-3, MMP-9, MMP-13 and ADAMTS-4, with concomitant decrease in the Col II and aggrecan contents. 99 This discrepancy may be attributed to the differences in the types of cells, and cultural system.
| lncRNAs regulate the inflammatory response
Inflammation is increasingly being recognized as an important driver of OA cartilage pathology. They found that their expression is significantly decreased in both knee and hip OA cartilage compared with non-OA cartilage. 106 In human chondrocyte TC28 cell line, knockdown of CILinc01 or CILinc02 dramatically enhances IL-1β-stimulated production of IL-6, IL-8, TNF-α, macrophage inflammatory protein (MIP-1β) and granulocyte-colony stimulating factor (G-CSF), suggesting a protective role of these two lncRNAs in controlling inflammation-driven cartilage degeneration in OA.
| LncRNAs regulate chondrocyte and synoviocyte apoptosis
Apoptosis, also called type I programmed cell death, is a highly regulated pathway that involves specific sets of intracellular signals and genes. Dysregulation of apoptosis results in pathological states, such as cancer, developmental anomalies and degenerative diseases. 107, 108 During apoptosis, cells show morphological characteristics including cell shrinkage, plasma membrane blebbing, chromatin condensation, DNA fragmentation and apoptotic body formation. 109 Chondrocytes play a crucial role in maintaining articular integrity and physiology via the synthesis of ECM components to resist mechanical loads. It is well established that reduced chondrocyte number due to apoptosis is a critical cause leading to cartilage degeneration in the process of OA. 114 Similarly, the exogenous induction of GAS5 in normal human chondrocytes decreases miR-21 levels and then stimulate apoptosis, leading to a severe degenerative morphology. 99 In primary rabbit condylar chondrocytes, knockdown of HOTAIR is also found to attenuate the apoptosis rate induced by IL-1β. 84 Therefore, inhibition of GAS5 or HOTAIR may have a potential therapeutic benefit for OA patients through the blockage of chondrocyte apoptosis.
Synovitis is one of the most important characteristics of OA, presenting with pathological features including hyperplasia of the synovial lining and inflammatory cell infiltration. 115 Activated synoviocytes secrete a number of proinflammatory cytokines such as IL-1β, TNF-α and IL-6, which block cartilage turnover and promote the produce of MMPs and cathepsins, resulting in the destruction of bone and cartilage. 116 In contradiction with chondrocytes, increased number of synoviocytes thus contributes to the development of OA. A recent experimental study by Kang et al. has demonstrated that prostate cancer gene expression marker 1 (PCGEM1), a lncRNA, is highly expressed in human OA synoviocytes. 117 Moreover, exogenous overexpression of PCGEM1 markedly inhibits apoptosis and stimulates the proliferation of human OA synoviocytes by directly binding to miR-770. 117 Thus, reduced synoviocyte apoptosis may be one of the mechanisms by which activation of PCGEM1 promotes OA progression.
| LncRNAs regulate the angiogenesis
Angiogenesis, defined as blood vessel outgrowth from pre-existing vasculature, is indispensable for growth and development, the reproductive cycle and tissue repair. 118 As articular cartilage and the inner two-thirds of the meniscus are normally avascular, they depend on oxygen and nutrients from adjacent synoviocytes and synovial blood vessels via the synovial fluid. 119, 120 There has been a large body of evidence supporting the involvement of angiogenesis in OA development. [121] [122] [123] Angiogenesis is modulated by the equilibrium of proangiogenic and anti-angiogenic factors, which is regulated by the presence of either a facilitating or inhibitory ECM environment. Pathological neovascularization in OA represents a breakdown of these normal homeostatic 
| POSSIBLE THERAPEUTIC APPROACHES FOR TARGETING LNCRNAS IN IDD AND OA
The onset and development of IDD and OA has been regarded as a 
| Antisense oligonucleotides

| Small molecule inhibitors
Small molecule inhibitors are another therapeutic strategy. These inhibitors are designed to suppress lncRNA expression or to hide the binding sites for lncRNAs and thereby antagonize the interaction with specific partners. It has been reported that bromodomain-containing 4 (BRD4), a small molecule inhibitor, can downregulate HOTAIR expression and then inhibit glioblastoma tumour growth. 138 Another small molecule inhibitor that blocks the binding of HOTAIR to its partners is also found to protect against tumour cell proliferation, invasion and metastasis. 139 Given the fact that HOTAIR plays an important role in promoting OA progression, 84 in vivo delivery of small molecule inhibitors for HOTAIR may have a potential therapeutic benefit for OA patients.
| Zinc finger nucleases
Zinc finger nucleases (ZFNs) are genetically engineered proteins that contain a DNA-binding domain composed of at least three Cys 2 His 2 zinc fingers and a non-specific DNA cleavage domain derived from the restriction endonuclease FokI. 140 The zinc finger domains can be engineered to target a specific nucleotide sequence. The fused nuclease domain creates a DNA double-strand break at this specific site after dimerization, thus conferring a knockout-like effect on gene functions. Recently, ZFNs have been successfully employed to downregulate MALAT1 expression, with a 1000-fold reduction. 141 Thus, this approach is far superior to RNAi technique so as to knockdown a lncRNA.
| CONCLUSIONS AND FUTURE DIRECTIONS
Despite the investigations of lcnRNAs remaining in their infancy, they have been suggested as new contributors to IDD and OA. This provides novel insight into the pathogenesis of IDD and OA. With continued efforts, some dysregulated lncRNAs may be used as valuable diagnostic biomarkers and therapeutic targets. However, many challenges are still ahead. Thousands of lncRNAs have been shown to be differentially expressed in IDD and OA, whereas there is still a lack of the effects of single lncRNA on IDD and only nine lncRNAs are proved to involve OA to date. Thus, it is important to elucidate the role of more other lncRNAs in IDD and OA development.
LncRNAs are known to act as natural miRNA sponges, and there has been a large body of evidence supporting the involvement of miRNAs in IDD 1 and OA. [142] [143] [144] Future studies should also focus on the novel crosstalk between lncRNAs and miRNAs during IDD and OA.
Although in vitro studies may provide promising results with regard to lncRNAs involving both diseases, in vivo validation will be necessary. As discussed above, several approaches to target lncRNAs for therapeutic purposes can be considered once key disease-relevant contributions of these genes have been identified. A major challenge of all of these approaches is to accomplish target-specific delivery.
Recently, several novel delivery strategies have been developed to reduce off-target effects, especially nanoparticles that are characteristic by improved stability, extremely small size, biocompatibility and selfassembly. 145, 146 Administration of HOTAIR siRNA by using magnetic nanoparticles has been shown to effectively inhibit the proliferation, invasion and in vivo tumourigenicity of human glioma stem cells.
147
The use of nanoparticles as effective delivery vehicles for lncRNAs is thus highly attractive and deserves further studies. As the pace of research in lncRNAs progresses, addressing these issues will provide opportunities for the development of novel therapeutic strategies based on targeting lncRNAs for IDD and OA.
